TS 041
Alternative Names: TS-041Latest Information Update: 16 Jul 2016
At a glance
- Originator Janssen L.P.; Taisho Pharmaceutical
- Class Antidepressants; Anxiolytics
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Anxiety-disorders in Europe
- 16 Jul 2016 No recent reports of development identified for phase-I development in Major depressive disorder in Europe